FDA Warning re Bayer Aspirin

The FDA has issued a warning about two over-the-counter (OTC) products made by Bayer.

The FDA is considering the 2 products, Bayer Aspirin with Heart Advantage & Bayer Women's Low Dose Aspirin + Calcium, to be new drugs and that they need to go through the FDA approval process. Additionally, the FDA is concerned because Bayer is selling these over-the-counter, but that they need physician's supervision, and that the included usage instructions are misleading and contradictory.

The FDA recommends that consumers taking either of these types of aspirin contact their doctor to find an approved alternative.

Read the entire press release.

Journals and Videos Received in October 2008:

New Journal Issues

Annals of internal medicine

Annals of long-term care

Archives of internal medicine

Consultant

Cutis

Internal medicine news

JCOM

Modern healthcare

MPR

NIH Medline Plus

Oncology

Oncology news international

Oncology times

Outpatient surgery

Primary care companion to the journal of clinical psychiatry

Pulmonary reviews

Radiologic technology

Surgery news

Thanks to Dr. Lee, Dr. Miller-Dobalian, Dr. Lappat , Dr. Toumajian, Dr. Wong, and Dr. Kahn for journal and multimedia donations.